[1] Oz, G., Alger, J.R., Barker, P.B., Bartha, R. and Bizzi, A. (2014) MRS Consensus Group. Clinical Proton MR Spectroscopy in Central Nervous system Disorders. Radiology, 270, 658-679.
http://dx.doi.org/10.1148/radiol.13130531
[2] Burtscher, I.M. and Holtas, S. (2001) Proton MR Spectroscopy in Clinical Routine. Journal of Magnetic Resonance Imaging, 13, 560-567.
http://dx.doi.org/10.1002/jmri.1079
[3] Frahm, J., Merboldt, K.D. and Hanicke, W. (1969) Localised Proton Spectroscopy Using Stimulated Echoes. Journal of Magnetic Resonance, 72, 502-508.
[4] Gillard, J.H., Waldman, A.D. and Barker, P.B. (2005) Clinical MR Neuroimaging. Cambridge University Press, New York.
[5] Zimmerman, R.A. and Wang, Z.J. (1997) The Value of Proton MR Spectroscopy in Pediatric Metabolic Brain Disease. American Journal of Neuroradiology, 18, 1872-1879.
[6] Kreis, R., Ernst, T. and Ross, B.D. (1993) Absolute Quantitation of Water and Metabolites in the Human Brain. II, Metabolite Concentrations. Journal of Magnetic Resonance, Series B, 102, 9-19.
http://dx.doi.org/10.1006/jmrb.1993.1056
[7] Doyle, T.J., Bedell, B.J. and Narayana, P. (1995) Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain. Magnetic Resonance in Medicine, 33, 755-759.
http://dx.doi.org/10.1002/mrm.1910330603
[8] Soher, B.J., van Zijl, P., Duyn, J.H. and Barker, P.B. (1996) Quantitative Proton MR Spectroscopic Imaging of the Human Brain. Magnetic Resonance in Medicine, 35, 356-363.
http://dx.doi.org/10.1002/mrm.1910350313
[9] Maheshwari, S.R., Fatterpekar, G.M., Castillo, M. and Mukherji, S.K. (2000) Proton MR Spectroscopy of the Brain. Seminars in Ultrasound, CT and MRI, 21, 434-451.
http://dx.doi.org/10.1016/S0887-2171(00)90036-2
[10] Danielsen, E.R., Ross, B. and Danielsen, E.R. (1999) Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. Marcel Dekker, New York, 30-34.
[11] Castillo, M., Kwock, L., Scatliff, J. and Mukherji, S.K. (1998) Proton MR Spectroscopy in Neoplastic and Non-Neoplastic Brain Disorders. Magnetic Resonance Imaging Clinics of North America, 6, 1-20.
[12] Miller, B.L., Moats, R.A., Shonk, T., Ernst, T., Woolley, S. and Ross, B.D. (1993) Alzheimer Disease: Depiction of Increased Cerebral Myo-Inositol with Proton MR Spectroscopy. Radiology, 187, 433-437.
http://dx.doi.org/10.1148/radiology.187.2.8475286
[13] Ernst, T., Chang, L., Melchor, R. and Mehringer, C.M. (1997) Frontotemporal Dementia and Early Alzheimer Disease: Differentiation with Frontal Lobe H-1 MR Spectroscopy. Radiology, 203, 829-836.
http://dx.doi.org/10.1148/radiology.203.3.9169712
[14] Terek, D., Koroglu, O.A., Gunes, S., Yalaz, M., Akisu, M., U?ar, S.K., Gokben, S., Coker, M. and Kultursay, N. (2012) Diagnostic Tools of Metabolic and Structural Brain Disturbances in Neonatal Non-Ketotic Hyperglycinemia. Pediatrics International, 54, 717-720.
http://dx.doi.org/10.1111/j.1442-200X.2012.03591.x
[15] Wozniak, J.R. and Lim, K.O. (2006) Advances in White Matter Imaging: A Review of in Vivo Magnetic Resonance Methodologies and Their Applicability to the Study of Development and Aging. Neuroscience & Biobehavioral Reviews, 30, 762-774.
http://dx.doi.org/10.1016/j.neubiorev.2006.06.003
[16] Córdoba, J., Sanpedro, F., Alonso, J. and Rovira, A. (2002) 1H Magnetic Resonance in the Study of Hepatic Encephalopathy in Humans. Metabolic Brain Disease, 17, 415-429.
http://dx.doi.org/10.1023/A:1021926405944
[17] Novotny, E.J., Fulbright, R.K., Pearl, P.L., Gibson, K.M. and Rothman, D.L. (2003) Magnetic Resonance Spectroscopy of Neurotransmitters in Human Brain. Annals of Neurology, 54, 25-31.
http://dx.doi.org/10.1002/ana.10697
[18] O’Gorman, R.L., Michels, L., Edden, R.A., Murdoch, J.B. and Martin, E. (2011) In Vivo Detection of GABA and Glutamate with MEGA-PRESS: Reproducibility and Gender Effect. Journal of Magnetic Resonance Imaging, 33, 1262-1267.
http://dx.doi.org/10.1002/jmri.22520
[19] Lazovic, J., Soto, H., Piccioni, D., Ru, J.R.L., Li, S., Mirsadraei, L. and Pop, B.W. (2012) Detection of 2-Hydroxyglutaric Acid in Vivo by Proton Magnetic Resonance Spectroscopy in U87 Glioma Cells Overexpressing Isocitrate Dehydrogenase-1 Mutation. Neuro-Oncology, 14, 1465-1472.
[20] Elkhaled, A., Jalbert, L.E., Phillips, J.J., Yoshihara, H.A., Parvataneni, R., Srinivasan, R. and Nelson, S.J. (2012) Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas. Science Translational Medicine, 4, 116ra5.
[21] Kaminogo, M., Ishimaru, H., Morikawa, M., Ochi, M., Ushijima, R., Tani, M. and Shibata, S. (2001) Diagnostic Potential of Short Echo Time MR Spectroscopy of Gliomas with Single-Voxel and Point-Resolved Spatially Localized Proton Spectroscopy of Brain. Neuroradiology, 43, 353-363.
http://dx.doi.org/10.1007/s002340000473
[22] Zand, D.J., Simon, E.M., Pulitzer, S.B., Wang, D.J., Wang, Z.J., Rorke, L.B., Palmieri, M. and Berry, G.T. (2003) In Vivo Pyruvate Detected by MR Spectroscopy in Neonatal Pyruvate Dehydrogenase Deficiency. American Journal of Neuroradiology, 24, 1471-1474.
[23] Rae, C.D. (2014) A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain 1H Magnetic Resonance Spectra. Neurochemical Research, 39, 1-36.
http://dx.doi.org/10.1007/s11064-013-1199-5
[24] Panigrahy, A. and Blüml, S. (2009) Neuroimaging of Pediatric Brain Tumors: From Basic to Advanced Magnetic Resonance Imaging. Child Neurology, 24, 1343-1365.
http://dx.doi.org/10.1177/0883073809342129
[25] Blüml, S., Panigrahy, A., Laskov, M., Dhall, G., Krieger, M.D., Nelson, M.D. and Gilles, F.H. (2011) Elevated Citrate in Pediatric Astrocytomas with Malignant Progression. Neuro-Oncology, 13, 1107-1117.
http://dx.doi.org/10.1093/neuonc/nor087
[26] Mohammad, F.F., Hasan, D.I. and Ammar, M.G. (2014) MR Spectroscopy and Diffusion MR Imaging in Characterisation of Common Sellar and Supra-Sellar Neoplastic Lesions. The Egyptian Journal of Radiology and Nuclear Medicine, 45, 859-867.
http://dx.doi.org/10.1016/j.ejrnm.2014.04.012
[27] Yue, Q., Isobe, T., Shibata, Y., Anno, I., Kawamura, H., Yamamoto, Y. and Matsumura, A. (2008) New Observations Concerning the Interpretation of Magnetic Resonance Spectroscopy of Meningioma. European Radiology, 18, 2901-2911.
http://dx.doi.org/10.1007/s00330-008-1079-6
[28] Castillo, M., Kwock, L. and Mukherji, S.K. (1996) Clinical Applications of Proton MR Spectroscopy. American Journal of Neuroradiology, 17, 1-15.
[29] Gillard, J.H., Waldman, A.D. and Barker, P.B. (2005) Clinical MR Neuroimaging. Cambridge University Press, New York.
[30] Luthra, G., Parihar, A., Nath, K., Jaiswal, S., Prasad, K.N., Husain, N. and Gupta, R.K. (2007) Comparative Evaluation of Fungal, Tubercular, and Pyogenic Brain Abscesses with Conventional and Diffusion MR Imaging and Proton MR Spectroscopy. American Journal of Neuroradiology, 28, 1332-1338.
http://dx.doi.org/10.3174/ajnr.A0548
[31] Cecil, K.M. and Lenkinski, R.E. (1998) Proton MR Spectroscopy in Inflammatory and Infectious Brain Disorders. Neuroimaging Clinics of North America, 8, 863-880.
[32] Lai, P.H., Li, K.T., Hsu, S.S., Hsiao, C.C., Yip, C.W., Ding, S. and Pan, H.B. (2005) Pyogenic Brain Abscess: Findings from in Vivo 1.5-T and 11.7-T in Vitro Proton MR Spectroscopy. American Journal of Neuroradiology, 26, 279-288.
[33] Narayana, P.A. (2005) Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis. Journal of Neuroimaging, 15, 46-57.
http://dx.doi.org/10.1177/1051228405284200
[34] Narayana, P.A., Doyle, T.J., Lai, D. and Wolinsky, J.S. (1998) Serial Proton Magnetic Resonance Spectroscopic Imaging, Contrast-Enhanced Magnetic Resonance Imaging, and Quantitative Lesion Volumetry in Multiple Sclerosis. Annals of Neurology, 43, 56-57.
http://dx.doi.org/10.1002/ana.410430112
[35] Savranlar, A., Ozer, T., Aydemir, S., Alkan, A. and Borazan, A. (2005) Proton Magnetic Resonance Spectroscopy Findings of Wilson’s Disease Case Report. Journal of Neurological Sciences (Turkish), 22, 297-303.
[36] Saksena, S., Rai, V., Saraswat, V.A., Rathore, R.S., Purwar, A., Kumar, M. and Gupta, R.K. (2008) Cerebral Diffusion Tensor Imaging and in Vivo Proton Magnetic Resonance Spectroscopy in Patients with Fulminant Hepatic Failure. Journal of Gastroenterology and Hepatology, 23, 111-119.
http://dx.doi.org/10.1111/j.1440-1746.2007.05158.x
[37] Brand, A., Richter-Landsberg, C. and Leibfritz, D. (1993) Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells. Developmental Neuroscience, 15, 289-298.
http://dx.doi.org/10.1159/000111347
[38] Stafstrom, C.E. (2004) Dietary Approaches to Epilepsy Treatment: Old and New Options on the Men. Epilepsy Currents, 4, 215-222.
http://dx.doi.org/10.1111/j.1535-7597.2004.46001.x
[39] Rock, J.P., Hearshen, D., Scarpace, L., Croteau, D., Gutierrez, J., Fisher, J.L. and Mikkelsen, T. (2002) Correlations between Magnetic Resonance Spectroscopy and Image-Guided Histopathology, with Special Attention to Radiation Necrosis. Neurosurgery, 51, 912-920.
[40] Davanzo, P., Thomas, M.A., Yue, K., Oshiro, T., Belin, T., Strober, M. and McCracken, J. (2001) Decreased Anterior Cingulate Myo-Inositol/Creatine Spectroscopy Resonance with Lithium Treatment in Children with Bipolar Disorder. Neuropsychopharmacology, 24, 359-369.
http://dx.doi.org/10.1016/S0893-133X(00)00207-4
[41] Kleihues, P. and Cavenee, W.K. (2000) Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer, Lyon.
[42] Chinn, R.J., Wilkinson, I.D., Hall-Craggs, M.A., Paley, M.N., Miller, R.F., Kendall, B.E. and Harrison, M.J. (1995) Toxoplasmosis and Primary Central Nervous System Lymphoma in HIV Infection: Diagnosis with MR Spectroscopy. Radiology, 197, 649-654.
http://dx.doi.org/10.1148/radiology.197.3.7480733
[43] Schultz Jr., K.D., Petronio, J., Narad, C. and Hunter, S.B. (1997) Solitary Intracerebral Juvenile Xanthogranuloma. Pediatric Neurosurgery, 26, 315-321.
http://dx.doi.org/10.1159/000121212
[44] Howe, F.A., Barton, S.J., Cudlip, S.A., Stubbs, M., Saunders, D.E., Murphy, M. and Griffiths, J.R. (2003) Metabolic Profiles of Human Brain Tumors Using Quantitative in Vivo 1H Magnetic Resonance Spectroscopy. Magnetic Resonance in Medicine, 49, 223-232.
http://dx.doi.org/10.1002/mrm.10367
[45] Furuya, S., Naruse, S., Ide, M., Morishita, H.E., Kizu, O., Ueda, S. and Maeda, T. (1997) Evaluation of Metabolic Heterogeneity in Brain Tumors Using 1H-Chemical Shift Imaging Method. NMR in Biomedicine, 10, 25-30.
http://dx.doi.org/10.1002/(SICI)1099-1492(199701)10:1<25::AID-NBM445>3.0.CO;2-M